| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 63.27B | 67.50B | 61.57B | 54.49B | 48.38B | 45.32B |
| Gross Profit | 15.94B | 17.69B | 15.18B | 13.68B | 12.24B | 11.46B |
| EBITDA | 3.46B | 4.02B | 2.96B | 2.61B | 2.58B | 2.85B |
| Net Income | 1.43B | 927.00M | 992.00M | 1.21B | 1.18B | 1.48B |
Balance Sheet | ||||||
| Total Assets | 34.73B | 40.75B | 36.41B | 33.69B | 30.90B | 27.68B |
| Cash, Cash Equivalents and Short-Term Investments | 9.06B | 10.64B | 8.30B | 7.47B | 7.01B | 7.29B |
| Total Debt | 2.48B | 3.42B | 2.87B | 2.96B | 2.81B | 2.12B |
| Total Liabilities | 20.41B | 24.87B | 22.06B | 20.47B | 18.40B | 16.28B |
| Stockholders Equity | 12.25B | 13.32B | 12.24B | 11.41B | 10.54B | 9.44B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.97B | 1.29B | 1.42B | 1.37B | 1.76B |
| Operating Cash Flow | 0.00 | 3.79B | 1.42B | 1.52B | 1.59B | 2.23B |
| Investing Cash Flow | 0.00 | -1.76B | -218.00M | -268.00M | -2.05B | -725.00M |
| Financing Cash Flow | 0.00 | 264.00M | -475.00M | -813.00M | 56.00M | -871.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥16.75B | 13.03 | ― | 3.53% | 3.36% | -23.56% | |
65 Neutral | ¥9.22B | 9.64 | ― | 3.85% | -6.67% | 34.46% | |
63 Neutral | ¥20.02B | 27.91 | ― | ― | 25.92% | -10.55% | |
62 Neutral | ¥11.49B | 11.79 | ― | 1.47% | 9.63% | -6.56% | |
62 Neutral | ¥3.16B | 10.26 | ― | ― | 8.20% | 2.55% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
45 Neutral | ¥3.54B | -89.25 | ― | ― | 14.31% | ― |